---
title: "Shanghai MicroPort MedBot’s Surgical Robot Gains Regulatory Approval"
date: "2025-02-12 07:11:25"
summary: "Maximize Your Portfolio with Data Driven Insights:Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions. Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart PortfolioAn update from Shanghai MicroPort MedBot..."
categories:
  - "tipranks_announcements"
lang:
  - "en"
translations:
  - "en"
tags:
  - "tipranks_announcements"
menu: ""
thumbnail: "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1911898180-750x406.jpg"
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

### Maximize Your Portfolio with Data Driven Insights:

* Leverage the power of [TipRanks' Smart Score](https://www.tipranks.com/screener/top-smart-score-stocks), a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
* Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with  [Your Smart Portfolio](https://www.tipranks.com/smart-portfolio/holdings)

An update from Shanghai MicroPort MedBot (Group) Co., Ltd. Class H ( [(HK:2252)](https://www.tipranks.com/stocks/hk:2252) ) is now available.

Shanghai MicroPort MedBot has received approval from the National Medical Products Administration of China for its Toumai Single-arm and Single-port Laparoscopic Surgical Robot. This approval marks a significant milestone in the company’s business development, enhancing its product portfolio and market competitiveness. The Toumai Single-arm robot, characterized by its unique single-arm structure and sophisticated design, offers clinical advantages such as smaller wounds and less pain, thus improving post-operative aesthetics. This development is expected to strengthen the company’s position in both the domestic and international markets.

**More about Shanghai MicroPort MedBot (Group) Co., Ltd. Class H**

Shanghai MicroPort MedBot (Group) Co., Ltd. operates in the surgical robot industry, focusing on precision medicine with a specialization in developing intelligent surgical solutions. It is known for its full-chain self-production and self-development capabilities, providing comprehensive solutions for both domestic and international markets.

**YTD Price Performance:** 95.37%

**Average Trading Volume:** 14,754,864

**Technical Sentiment Consensus Rating:** Sell

**Current Market Cap:** HK$15.41B

For an in-depth examination of 2252 stock, go to [TipRanks’ Stock Analysis page](https://www.tipranks.com/stocks/hk:2252/stock-analysis).

Trending Articles:
------------------

* [M&A News: Paramount (NASDAQ:PARA) Merger Wins EU Approval](https://www.tipranks.com/news/ma-news-paramount-nasdaqpara-merger-wins-eu-approval)
* [Ford (NYSE:F) F-250 Super Duty Takes a Big Win in Value](https://www.tipranks.com/news/ford-nysef-f-250-super-duty-takes-a-big-win-in-value)
* [Intel (NASDAQ:INTC) Gets a Powerful Friend In JD Vance](https://www.tipranks.com/news/intel-nasdaqintc-gets-a-powerful-friend-in-jd-vance)

[tipranks_announcements](https://www.tipranks.com/news/company-announcements/shanghai-microport-medbots-surgical-robot-gains-regulatory-approval)
